REG - BkofA Merrill Lynch Aon PLC - Form 38.5 (b) - Aon Plc
RNS Number : 0350UBank of America Merrill Lynch24 July 2020FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
BofA Securities, Inc.
Company dealt in
Aon PLC
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - IE00BLP1HW54
Date of dealing
23/07/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
IE00BLP1HW54
Long
Short
Number
%
Number
%
(1)
Relevant securities
146,878
0.063%
377,407
0.163 %
(2)
Derivatives (other than options):
199,108
0.086%
130,704
0.056%
(3)
Options and agreements to purchase/sell:
0
0%
8,500
0.004%
Total
345,986
0.149%
516,611
0.223%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
2,560
207.37 USD
Purchase
1
206.68 USD
Purchase
216
206.86 USD
Purchase
1
206.97 USD
Purchase
2
207.07 USD
Purchase
11
207.08 USD
Purchase
98
207.1 USD
Purchase
1
207.26 USD
Purchase
1
207.3 USD
Purchase
46,496
207.37 USD
Purchase
1
207.42 USD
Purchase
1
207.48 USD
Purchase
1
207.51 USD
Purchase
1
207.52 USD
Purchase
1
207.61 USD
Purchase
1
207.65 USD
Purchase
1
207.67 USD
Purchase
1
207.78 USD
Purchase
300
207.829 USD
Purchase
1
207.83 USD
Purchase
95
207.87 USD
Purchase
216
207.89 USD
Purchase
13
207.9 USD
Purchase
1
208.08 USD
Purchase
1
208.12 USD
Purchase
100
208.23 USD
Purchase
8
208.35 USD
Purchase
108
208.37 USD
Purchase
1
208.42 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
2
206.36 USD
Sale
8
206.39 USD
Sale
100
206.4 USD
Sale
108
206.49 USD
Sale
215
206.5 USD
Sale
4
206.53 USD
Sale
218
206.55 USD
Sale
2
206.62 USD
Sale
23
206.64 USD
Sale
6
206.71 USD
Sale
2
206.73 USD
Sale
101
206.74 USD
Sale
18
206.76 USD
Sale
90
206.77 USD
Sale
4
206.78 USD
Sale
2
206.8 USD
Sale
115
206.81 USD
Sale
2
206.82 USD
Sale
222
206.86 USD
Sale
108
206.88 USD
Sale
4
206.9 USD
Sale
2
206.91 USD
Sale
101
206.97 USD
Sale
108
207 USD
Sale
1
207.02 USD
Sale
2
207.05 USD
Sale
67
207.07 USD
Sale
2
207.08 USD
Sale
6
207.1 USD
Sale
2
207.11 USD
Sale
3
207.13 USD
Sale
36
207.14 USD
Sale
1
207.16 USD
Sale
2
207.18 USD
Sale
9
207.23 USD
Sale
2
207.26 USD
Sale
2
207.27 USD
Sale
2
207.28 USD
Sale
3
207.3 USD
Sale
108
207.32 USD
Sale
203
207.33 USD
Sale
218
207.34 USD
Sale
108
207.38 USD
Sale
2
207.39 USD
Sale
8
207.43 USD
Sale
84
207.47 USD
Sale
2
207.48 USD
Sale
3
207.52 USD
Sale
100
207.54 USD
Sale
8
207.55 USD
Sale
217
207.56 USD
Sale
108
207.57 USD
Sale
1
207.58 USD
Sale
108
207.64 USD
Sale
84
207.71 USD
Sale
24
207.75 USD
Sale
108
207.85 USD
Sale
7
207.91 USD
Sale
108
207.92 USD
Sale
216
207.93 USD
Sale
1
207.94 USD
Sale
100
207.98 USD
Sale
200
208.09 USD
Sale
100
208.13 USD
Sale
47
208.32 USD
Sale
59
208.33 USD
Sale
215
208.34 USD
Sale
1,072
208.35 USD
Sale
140
208.36 USD
Sale
3
208.38 USD
Sale
6
208.59 USD
Sale
80
207.347 USD
Sale
20
207.37 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)Swaps
Increasing a Short Position
40,000
207.37 USD
Swaps
Increasing a Short Position
5,934
207.37 USD
Swaps
Reducing a Long Position
394
207.376 USD
Swaps
Reducing a Long Position
200
207.829 USD
Swaps
Reducing a Long Position
100
207.829 USD
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)
Loan
Loan of 97 shares
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
Yes
Date of disclosure
24/07/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
Willis Towers Watson PLC
Nature of connection (Note 9)
Advisor to - Willis Towers Watson PLC
SUPPLEMENTAL FORM 38.5(b)
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
Product name,
e.g. call optionWritten or
purchasedNumber of securities to which the option or derivative relates
Exercise price
(Note 2)Type, e.g.
American,
European etcExpiry date
Call Option
Written
8,500
210 USD
American
21/08/2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDISEKKQBPCBKKPOB
Recent news on Aon
See all newsRCS - Rothesay Life PLC - Bruce Carnegie-Brown appointed Chair of Rothesay
AnnouncementRCS - Rothesay Life PLC - Rothesay Full-Year Trading Update
AnnouncementREG - WCM Investment Mgmt Aon PLC - Form 8.3 - Aon PLC
AnnouncementREG - Credit Suisse (Eur) Aon PLC - Form 38.5(a) - Aon plc
AnnouncementREG - Credit Suisse Cap. Aon PLC - Form 38.5(b) - Aon plc
Announcement